Definitions & Terms in Cancer

Our foundation believes that we can assist patients in better understanding the complex terminology and definitions to facilitate their decision-making process in choosing the types of therapy for organ confined cancers as well as cancers which have already spread to other organs.

PET/CAT fused scan Tells Structure (CAT) How Much Sugar the Cancer Consumes (PET- using F Deoxyglucose Uptake)- We believe using a Multi-Modality approach and to Encourage People to Empower Themselves to “Starve the Cancer Cell by using” by using Calorie Restricted Optimal Nutrition Ketosis and Medium Chain Fatty Acids which can “starve the cancers” for a finite time before cancer mutation and adaptation.

One of the respectable oncologist named Michael P. Lasanti MD PhD just moved from the United States just moved to United Kingdom University of Salford Manchester to focus on cancer micro environment intervention and will be studying many drugs available to bring many old drugs as repurposed drugs to be used in the near future.

Targeted therapy is a type of cancer treatment that targets proteins that control how cancer cells grow, divide, and spread. It is the foundation of precision medicine. As researchers learn more about the DNA changes and proteins that drive cancer, they are better able to design treatments that target these proteins. The TCGA cancer genome atlas did not show an uniform genome for each cancer as expected, but small breakthroughs came as a new discovery of mutations in certain cancers and this was the beginning of more targeted therapy.

First developed by Dr. William D. Kelley, the Protease Enzyme Protocol has historically been shown to be an effective cancer treatment. Dr. Kelley formulated this protocol and cured himself of pancreatic cancer.

Two of his students, Nutritionist Pamela McDougle of Idaho and the late Nick Gonzales, MD, of New York City, resurrected this old form of cancer treatment and have found it especially effective in pancreatic cancer. Pamela has been in practice since the 1990s and has seen over 5000 patients using protease enzymes. The late Dr. Gonzales championed this methodology and collaborated with Columbia University Medical Center, in a failed attempt to conduct a formal clinical study evaluating the protocol.